Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02550171 · ClinicalTrials.gov registry record
BioGene Bank Cohort Study for Approved Research Requests
A clinical trial, sponsored by Northwell Health.
- Completed
- Registry status
- 7,056
- Enrollment target
NCT02550171: Completed study, sponsored by Northwell Health.
NCT02550171 is a clinical trial that has completed, run by Northwell Health. The registered enrollment target is 7,056 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02550171 has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- 7,056 participants
- Enrollment target
Study Summary
The BioGene bank: Is a centralized collection of human blood samples along with de-identified (coded) health information, environmental factors, family disease histories and information from DNA. Limited to the NSLIJHS catchment area.
Primary Outcome
Documentation of symptoms to diagnosis of autoimmune disease(s)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,056 participants |
| Start Date | 2009-03 |
| Est. Completion | 2014-08 |
What the finished NCT02550171 record still lists
NCT02550171 is an observational study that tracks outcomes without assigning an intervention. Its 7,056 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT02550171 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02550171 about?
NCT02550171 is a clinical study titled "BioGene Bank Cohort Study for Approved Research Requests". The BioGene bank: Is a centralized collection of human blood samples along with de-identified (coded) health information, environmental factors, family disease histories and information from DNA. Limited to the NSLIJHS catchment area.
What is the current status of trial NCT02550171?
This trial is currently completed. The enrollment target is 7,056 participants. The study started on 2009-03. Estimated completion is 2014-08.
Who is sponsoring clinical trial NCT02550171?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06843720 · 7,100 participants · NA
Expanding Access to Cervical Cancer Screening Through Primary HR-HPV Testing and Self-sampling: a Multicomponent Intervention for Safety Net Health Systems
- NCT00260585 · 7,000 participants
Esophageal Cancer Risk Registry
- NCT04118660 · 7,000 participants
Thoracic Specimen Registry
- NCT07106879 · 7,000 participants
Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia